STOK – stoke therapeutics, inc. (US:NASDAQ)
Stock Stats
News
Stoke Therapeutics (STOK) May Find a Bottom Soon, Here's Why You Should Buy the Stock Now [Yahoo! Finance]
Wall Street Analysts Believe Stoke Therapeutics (STOK) Could Rally 66.84%: Here's is How to Trade [Yahoo! Finance]
Stoke Therapeutics, Inc. (NASDAQ: STOK) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $22.00 price target on the stock.
Stoke Therapeutics, Inc. (NASDAQ: STOK) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $35.00 price target on the stock.
Need To Know: Analysts Are Much More Bullish On Stoke Therapeutics, Inc. (NASDAQ:STOK) Revenues [Yahoo! Finance]
Form SC 13G/A Stoke Therapeutics, Inc. Filed by: Redmile Group, LLC
Form SC 13G Stoke Therapeutics, Inc. Filed by: BAKER BROS. ADVISORS LP
Form SC 13G/A Stoke Therapeutics, Inc. Filed by: Lynx1 Capital Management LP
Form SC 13G/A Stoke Therapeutics, Inc. Filed by: VANGUARD GROUP INC
Form 4 Stoke Therapeutics, Inc. For: Nov 01 Filed by: Ticho Barry
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.